Founded in 2003 at 4055 Stephens Street in Mission Hills by former Biosite Diagnostics commercial lead Scott Mader, Clindevor Tri-Med operates as CLINDEVOR360 — an evidence-based strategic marketing and business planning consultancy for pharmaceutical, diagnostic, and medical device companies. Diagnostic-brand engagements include mapping reference labs and imaging providers such as Imaging Healthcare Specialists - Hillcrest into real-world-evidence programs and launch-market sizing for new test rollouts. The C360 planning methodology builds Realistic Clinical Profile analyses using referenced data, advisory input, and stakeholder expertise to drive objectified launch decisions across more than twenty therapeutic categories. Device-brand work extends to procedural-adoption strategy that benchmarks KOL networks against San Diego surgical groups including Pacific Coast Surgical Group during early-adopter cohort planning. Engagements cover the full brand lifecycle: clinical development planning, pre-launch positioning, launch-mode commercial implementation, and mature-brand repositioning for biotechnology and biopharmaceutical portfolios. The most complex projects pair competitive-landscape analysis with stakeholder advisory synthesis to produce launch strategies for first-in-class diagnostic or device brands entering therapeutic areas with no incumbent standard of care.